Pharmaceuticals, Biotechnology and Life Sciences
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications,…
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new AUSTEDO® (deutetrabenazine) data will be presented at the 32nd annual Psych Congress, October 3-6, 2019 in San Diego, California.
MJH Life Sciences said Wednesday it has promoted Mike Hennessy Jr. to dual role of president/CEO, effective today.
Believes Company’s Board has Abandoned its Fiduciary Duties by Choosing to Sell Progenics at Massive Discount in Attempt to Prevent…
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Graybug Vision, Inc., a clinical stage pharmaceutical company developing potentially transformative long-acting therapies for ocular diseases, including…
TOULOUSE, France–(BUSINESS WIRE)–Micropep Technologies, an AgTech startup addressing future agriculture needs by discovering novel natural molecules helping plants to unleash…
The biopharmaceutical development partner will remain anonymous due to competitive reasons. The companies will collaborate on the formulation and screening…
EAST BRUNSWICK, N.J.–(BUSINESS WIRE)–Rising Pharma Holdings Inc. (“Rising Pharmaceuticals”), today announced the U.S. launch & commercialization of six new generic…
DUBLIN–(BUSINESS WIRE)–The “Pancreatic Cancer – Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering. The Global Pancreatic Cancer…
– Combined entity will enable significant developments in high-value indications beyond NASH blockbuster opportunity SAN DIEGO–(BUSINESS WIRE)–Viscient Biosciences (“Viscient”), a…